We are live on ! Find out more
BDF

Balasa Dinverno & Foltz Portfolio holdings

AUM $1.58B
1-Year Est. Return 17.55%
This Fund
S&P 500
This Quarter Est. Return
+4%
1 Year Est. Return
-17.55%
3 Year Est. Return
+23.2%
5 Year Est. Return
+47.16%
10 Year Est. Return
AUM
$690M
AUM Growth
+$30.2M
Cap. Flow
+$4.69M
Cap. Flow %
0.68%
Top 10 Hldgs %
73.54%
Holding
235
New
25
Increased
97
Reduced
81
Closed
9

Top Buys

Rank Stock Value
1
WTV icon
WisdomTree US Value Fund
WTV
+$2.17M
2
EL icon
Estee Lauder
EL
+$1.38M
3
MU icon
Micron Technology
MU
+$891K
4
PRU icon
Prudential Financial
PRU
+$670K
5
T icon
AT&T
T
+$570K

Sector Composition

Rank Sector Weight
1 Technology 6.01%
2 Healthcare 3.83%
3 Financials 2.82%
4 Communication Services 2.16%
5 Consumer Discretionary 1.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QQQ icon
76
Invesco QQQ Trust
QQQ
$480B
$700K 0.1%
4,079
+125
+3% +$21K
ORCL icon
77
Oracle
ORCL
$437B
$694K 0.1%
15,762
-401
-2% -$18.5K
ABT icon
78
Abbott
ABT
$188B
$688K 0.1%
11,278
+25
+0.2% +$1.52K
NOC icon
79
Northrop Grumman
NOC
$82.3B
$687K 0.1%
2,232
+148
+7% +$48.9K
MMM icon
80
3M
MMM
$93.8B
$686K 0.1%
4,172
-1,312
-24% -$224K
ESRX
81
DELISTED
Express Scripts Holding Company
ESRX
$685K 0.1%
8,877
+3,011
+51% +$226K
PG icon
82
Procter & Gamble
PG
$339B
$684K 0.1%
8,765
-350
-4% -$26.3K
UAL icon
83
United Airlines
UAL
$40.6B
$671K 0.1%
9,630
+54
+0.6% +$3.75K
KBH icon
84
KB Home
KBH
$3.45B
$669K 0.1%
24,572
-1,550
-6% -$41.7K
HZNP
85
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$662K 0.1%
40,000
-9,000
-18% -$137K
IWO icon
86
iShares Russell 2000 Growth ETF
IWO
$14.9B
$651K 0.09%
3,184
HON icon
87
Honeywell
HON
$77B
$648K 0.09%
4,983
-163
-3% -$21.7K
AET
88
DELISTED
Aetna Inc
AET
$642K 0.09%
3,497
-29
-0.8% -$5.17K
DXC icon
89
DXC Technology
DXC
$1.74B
$626K 0.09%
7,766
-1,281
-14% -$110K
VBR icon
90
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.9B
$595K 0.09%
4,379
-273
-6% -$36.6K
VTV icon
91
Vanguard Morningstar Value ETF
VTV
$192B
$595K 0.09%
5,731
-674
-11% -$70.6K
EQR icon
92
Equity Residential
EQR
$24.6B
$593K 0.09%
9,311
+120
+1% +$7.48K
WBA
93
DELISTED
Walgreens Boots Alliance
WBA
$588K 0.09%
9,797
-328
-3% -$21.1K
IVE icon
94
iShares S&P 500 Value ETF
IVE
$49.9B
$585K 0.08%
5,309
-581
-10% -$64.4K
LYB icon
95
LyondellBasell Industries
LYB
$20B
$583K 0.08%
5,303
+2,157
+69% +$237K
TJX icon
96
TJX Companies
TJX
$177B
$583K 0.08%
12,252
+440
+4% +$19.3K
DHR icon
97
Danaher
DHR
$145B
$582K 0.08%
6,657
+370
+6% +$33K
IWM icon
98
iShares Russell 2000 ETF
IWM
$81.4B
$573K 0.08%
3,498
-134
-4% -$21.4K
GPOR
99
DELISTED
Gulfport Energy Corp.
GPOR
$573K 0.08%
+45,573
New +$470K
NEE icon
100
NextEra Energy
NEE
$176B
$570K 0.08%
13,656
+1,872
+16% +$75.6K

Similar funds

Balasa Dinverno & Foltz's Q2 2018 Portfolio in Review

As of Q2 2018, Balasa Dinverno & Foltz held 235 positions worth $690M, up 4.6% from $660M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Balasa Dinverno & Foltz's Q2 2018 filing shows 25 new, 97 increased, 81 reduced and 9 closed positions. Its largest new stake was WisdomTree US Value Fund: 52,906 shares worth $2.18M. The largest sale was iShares Russell 1000 Growth ETF, an estimated $3.16M.

By sector, the portfolio is most concentrated in Technology at 6% of assets, up from 5.9% a quarter earlier, followed by Healthcare and Financials.

  • Balasa Dinverno & Foltz's largest Q2 2018 buy was WisdomTree US Value Fund: 52,906 shares worth $2.18M.
  • Balasa Dinverno & Foltz added most to Micron Technology in Q2 2018, an estimated $891K increase.
  • Balasa Dinverno & Foltz's biggest Q2 2018 reduction was iShares Russell 1000 Growth ETF, cutting an estimated $3.16M.
  • Balasa Dinverno & Foltz fully exited Time Warner Inc in Q2 2018, selling an estimated $541K.
  • Balasa Dinverno & Foltz's ten largest holdings make up 74% of its $690M portfolio in Q2 2018.
  • Balasa Dinverno & Foltz opened 25 new positions and closed 9 in Q2 2018.
  • Balasa Dinverno & Foltz's portfolio value rose 4.6% quarter-over-quarter to $690M.

Based on Balasa Dinverno & Foltz's 13F filing for Q2 2018, filed 1 Aug 2018.